Navigation Links
AACR, NCI and EORTC to host molecular targets and cancer therapeutics conference

What: The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics is the location to hear about late-breaking data on emerging cancer therapies. This year's conference brings together delegates from all over the world to discuss innovation in drug development, target selection and the impact of new discoveries in molecular and cell biology.

To help you plan your coverage of the conference, the program schedule is available online at Although the full abstracts will not be available until the conference, an electronic press kit containing the press releases and select highlighted abstracts will be available to subscribing reporters on Nov. 9, 2009, via Eurekalert and Newswise, and by request to the AACR Communications and Public Relations Department.

More than 1,000 abstracts will be presented for the first time at the conference, complementing an outstanding program of scientific and educational events. The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics attracts world leaders in cancer research and treatment, including clinical oncologists, industry leaders, basic scientists and translational researchers who are working to improve patient care with the ultimate goal of eradicating cancer.

When: Nov. 15-19, 2009

Where: Hynes Convention Center, Boston


Contact: Natalie Poole
American Association for Cancer Research

Page: 1

Related biology news :

1. AACR, BCRF award inaugural grants in translational breast cancer research
2. Media invitation: 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics
3. New molecular regulators of hyperthyroidism and goiter
4. Carnegie Mellon scientists investigate initial molecular mechanism that triggers neuronal firing
5. UC health news: molecular pathway may predict chemotherapy effectiveness
6. New molecular clock from LLNL and CDC indicates smallpox evolved earlier than believed
7. Story ideas from Molecular & Cellular Proteomics
8. Lets talk -- new paradigms in the research of the biomolecular composition of water
9. Scientists unveil structure of molecular target of many drugs
10. Potential new therapeutic molecular target to fight cancer
11. NIH selects LIAI for major study on allergy molecular causes and possible treatments
Post Your Comments:
(Date:11/19/2015)... MOUNTAIN VIEW, Calif. , Nov. 19, 2015 /PRNewswire/ ... authentication market, Frost & Sullivan recognizes BIO-key with the ... Strategy Leadership. Each year, Frost & Sullivan presents this ... comprehensive product line catering to the needs of the ... which the product line meets and expands on customer ...
(Date:11/18/2015)... 2015 --> ... market report titled  Gesture Recognition Market - Global Industry ... 2021. According to the report, the global gesture recognition market was valued ... reach US$29.1 bn by 2021, at a CAGR of ... America dominated the global gesture recognition market ...
(Date:11/17/2015)... Nov. 17, 2015  Vigilant Solutions announces today that ... Board of Directors. --> ... retiring from the partnership at TPG Capital, one of ... over $140 Billion in revenue.  He founded and led ... the TPG companies, from 1997 to 2013.  In his ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... Germany , November 30, 2015 ... Vienna, Austria to be held December ... (ECNR) in Vienna, Austria to ... wholly owned subsidiary of Vycor Medical, Inc. ("Vycor") (OTCQB: VYCO), ... NovaVision Therapy Suite at the 3rd European Congress of ...
(Date:11/27/2015)... , Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: ... today that it has closed the sale of its ... Guerbet (GBT- NYSE Euronext) in a transaction valued at ... manufacturing facilities and a total of approximately 1,000 employees ... St. Louis area. This entire ...
(Date:11/25/2015)... , November 26, 2015 ... Biobanking Market 2016 - 2020 report analyzes that ... integrity and quality in long-term samples, minimizing manual ... cost-effectiveness. Automation minimizes manual errors such as mislabeling ... efficiency. Further, it plays a vital role in ...
(Date:11/25/2015)... 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... and CEO of Neurocrine Biosciences, will be presenting at ... New York . .   ... approximately 5 minutes prior to the presentation to download ... presentation will be available on the website approximately one ...
Breaking Biology Technology: